ROR1-AS1: A Meaningful Long Noncoding RNA in Oncogenesis

Title:ROR1-AS1: A Meaningful Long Noncoding RNA in Oncogenesis

Volume: 24 Issue: 21

Author(s): Hong Fan, Yunxi Zhou, Ziyan Zhang, Gang Zhou*Chengfu Yuan*

Affiliation:

• College of Traditional Chinese Medicine, China Three Gorges University, Yichang, 443002, China
• Yichang Hospital of Traditional Chinese Medicine, Yichang, 443002, China

• Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University
• College of Basic Medical Science, China Three Gorges University, Yichang 443002, China
• Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine, China Three Gorges University

Abstract:

Long noncoding RNA (lncRNA) is a non-coding RNA with a length of more than 200 nucleotides, involved in multiple regulatory processes in vivo, and is related to the physiology and pathology of human diseases. An increasing number of experimental results suggest that when lncRNA is abnormally expressed, it results in the development of tumors. LncRNAs can be divided into five broad categories: sense, antisense, bidirectional, intronic, and intergenic. Studies have found that some antisense lncRNAs are involved in a variety of human tumorigenesis. The newly identified ROR1-AS1, which functions as an antisense RNA of ROR1, is located in the 1p31.3 region of the human genome. Recent studies have reported that abnormal expression of lncRNA ROR1-AS1 can affect cell growth, proliferation, invasion, and metastasis and increase oncogenesis and tumor spread, indicating lncRNA ROR1-AS1 as a promising target for many tumor biological therapies. In this study, the pathophysiology and molecular mechanism of ROR1-AS1 in various malignancies are discussed by retrieving the related literature.

ROR1-AS1 is a cancer-associated lncRNA, and studies have found that it is either over- or underexpressed in multiple malignancies, including liver cancer, colon cancer, osteosarcoma, glioma, cervical cancer, bladder cancer, lung adenocarcinoma, and mantle cell lymphoma. Furthermore, it has been demonstrated that lncRNA ROR1-AS1 participates in proliferation, migration, invasion, and suppression of apoptosis of cancer cells.

Furthermore, lncRNA ROR1-AS1 promotes the development of tumors by up-regulating or downregulating ROR1-AS1 conjugates and various pathways and miR-504, miR-4686, miR-670-3p, and miR-375 sponges, etc., suggesting that lncRNA ROR1-AS1 may be used as a marker in tumors or a potential therapeutic target for a variety of tumors.

Cite this article as:

Fan Hong, Zhou Yunxi, Zhang Ziyan, Zhou Gang*, Yuan Chengfu*, ROR1-AS1: A Meaningful Long Noncoding RNA in Oncogenesis, Mini-Reviews in Medicinal Chemistry 2024; 24 (21) . https://dx.doi.org/10.2174/0113895575294482240530154620